Arca
Skip to content
Tools
Tools

Respiratory insufficiency

Drug research and approvals for respiratory insufficiency: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 22, 2026, 319 studies of respiratory insufficiency are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.

  • Recruiting worldwide: 319
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest posted first, of 319 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Approved 1

Phase 3 12 of 14

Phase 2 12 of 16

Phase 1 or earlier 8

How its trials ended

1,567 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 311 whose ending is known, 31% met their primary endpoint, 14% missed it and 56% stopped early.

  • Completed, result not reported64441%
  • Status unknown31520%
  • Ongoing29719%
  • Met its primary endpoint966%
  • Stopped: other or unclear886%
  • Stopped: enrollment or feasibility624%
  • Missed its primary endpoint423%
  • Stopped: lack of efficacy131%
  • Stopped: sponsor or business decision6<1%
  • Stopped: funding4<1%

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.